Neumous
Company
Neumous develops one asset, in human trials (NMS-01 in Alzheimer's disease). Mostly device.
- 1
- Asset
- Furthest stage
- Human trials
- 1
- Trial
- 2
- Signals
Pipeline
1Uses focused ultrasound to transiently open the blood-brain barrier.
Human trials, Device, Alzheimer's disease, blood brain barrier
Full company profiles: pipeline, trials, funding and people.
In the full profile
- Trials1
- Signals2
- Similar companies6